-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Pfizer, Raises Price Target to $25

Benzinga·04/30/2025 14:07:55
Listen to the news
UBS analyst Trung Huynh maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $24 to $25.